Treatment with naringin (60 mg/kg/d) significantly reduced myocardial TNF-α and IL-6 levels in T2D by 42 and 32%, respectively (p < 0.001 compared to untreated T2D mice (Figures 4A,B). This evidence concerns the gene IL6 and type 2 diabetes mellitus.